4
Changes in Ownership
CG Oncology, Inc. Filed Acc 0000950170-25-083236
Options or other derivatives
- Director acquired 24,165 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
CG Oncology, Inc. Filed Acc 0000950170-25-083236
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…